Extrachromosomal circular DNA and their roles in cancer progression

Extrachromosomal circular DNA and their roles in cancer progression

Extrachromosomal circular DNA (eccDNA), a chromosome-independent circular DNA, has garnered significant attention due to its widespread distribution and intricate biogenesis in carcinoma. Existing research findings propose that multiple eccDNAs contribute to drug resistance in cancer treatments thro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siqi Zheng, Yunong Li, Lin Wang, Qian Wei, Minjie Wei, Tao Yu, Lin Zhao
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-01-01
Series:	Genes and Diseases
Subjects:	Alternative splicing Cancer stem cell Extrachromosomal circle DNA Protein–protein interaction Tumor heterogeneity Tumor immune microenvironment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223004853
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unveiling the mysteries of extrachromosomal circular DNA: from generation to clinical relevance in human cancers and health
by: Zilong Wang, et al.
Published: (2024-12-01)

Integrating Circle-Seq with transcriptomics reveals genome-wide characterization of extrachromosomal circular DNA for dilated cardiomyopathy
by: Zhenhao Lin, et al.
Published: (2024-11-01)

Extrachromosomal circular DNA containing DTX1 promotes cell growth in hydroquinone-induced malignantly transformed cells by regulating the transcription of DTX1
by: Xiaoxuan Ling, et al.
Published: (2024-11-01)

Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
by: Zhuo Cheng, et al.
Published: (2025-02-01)

Leveraging AI to automate detection and quantification of extrachromosomal DNA to decode drug responses
by: Kohen Goble, et al.
Published: (2025-02-01)

DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma
by: Shuangyue Ma, et al.
Published: (2024-12-01)

The role of CD47 in immune escape of colon cancer and its correlation with heterogeneity of tumor immune microenvironment
by: Qiu-Si Tian, et al.
Published: (2024-12-01)

Editorial: Genetic and cellular heterogeneity in tumors
by: Zishan Wang, et al.
Published: (2024-12-01)

Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression
by: Yulan Huang, et al.
Published: (2025-03-01)

Heterogeneous nuclear ribonucleoprotein H1 and its function in tumor development and metastasis
by: ZHANG Zongwen, et al.
Published: (2024-12-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
by: Keerthi Ranganathan, et al.
Published: (2024-09-01)

Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer
by: Dequan Liu, et al.
Published: (2025-01-01)

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
by: Lili Wang, et al.
Published: (2025-02-01)

Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression
by: Lu Lu, et al.
Published: (2024-11-01)

Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights
by: Jinlong Wan, et al.
Published: (2024-11-01)

Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
by: Tingjie Wang, et al.
Published: (2024-11-01)

Characterization of alternative splicing during mammalian brain development reveals the extent of isoform diversity and potential effects on protein structural changes
by: Leila Haj Abdullah Alieh, et al.
Published: (2024-10-01)

Targeting RNA splicing modulation: new perspectives for anticancer strategy?
by: Xuemei Lv, et al.
Published: (2025-01-01)

Memories of a young student: the early days of splicing regulation with François Gros
by: Libri, Domenico
Published: (2024-01-01)

Identification of the whole genome of alternative splicing and RNA-binding proteins involved in nintedanib-induced apoptosis in gastric cancer cells
by: Xiaohua Dong, et al.
Published: (2024-12-01)

Tumor microbiome: roles in tumor initiation, progression, and therapy
by: Shengxin Zhang, et al.
Published: (2025-02-01)

Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer
by: Hannah J. Harris, et al.
Published: (2024-11-01)

KLF4: a multifunctional nexus connecting tumor progression and immune regulation
by: Yunjie Ju, et al.
Published: (2025-02-01)

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
by: Pingping Feng, et al.
Published: (2025-01-01)

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)

Exogenous plasmid capture to characterize tetracycline-resistance plasmids in sprouts obtained from retail in Germany
by: Maria Stein, et al.
Published: (2025-02-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
by: Minni Zhang, et al.
Published: (2025-01-01)

Stem Cells in Solid Tumors: Accumulated Evidence and Future Directions
by: Deepthi Venkatachalapathy, et al.
Published: (2024-04-01)

Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in breast cancer
by: Xiaozhou Yang, et al.
Published: (2025-01-01)

Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer
by: Xiao K. Ran, et al.
Published: (2025-01-01)

Research progress on the role and treatment of CD24 in the tumor microenvironment
by: YU Xinjing, et al.
Published: (2024-08-01)

Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy
by: Yanting Liu, et al.
Published: (2024-12-01)

Stanniocalcin-1 in tumor immunity: acts via macrophages
by: Lele Wang, et al.
Published: (2024-11-01)

Current advances on the role of ferroptosis in tumor immune evasion
by: Changlin Gao, et al.
Published: (2024-12-01)

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments
by: Xiaoke Wu, et al.
Published: (2024-11-01)

Prognostic and immune correlation of IDO1 promoter methylation in breast cancer
by: Shirong Ding, et al.
Published: (2024-11-01)

From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape
by: Mengqian Jiang, et al.
Published: (2024-11-01)

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
by: Geofrey F. Soko, et al.
Published: (2025-01-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)